Application of a novel pH-responsive gemini surfactant for delivery of curcumin molecules

During the last few decades, extensive studies have been conducted to elucidate the anti-cancer effects of curcumin. Despite promising results indicating curcumin could impede cancer cells ability thrive and proliferation, clinical applications of it have been limited. This limitation is mainly due to low solubility, poor bioavailability, rapid metabolism, and deficient absorption. To improve the physiochemical properties of curcumin, we have synthesized a novel biodegradable gemini surfactant in which curcumin molecules were entrapped. Gemini surfactant-curcumin nanocapsules were prepared using nanoprecipitation method and characterized by several techniques including, DLS, TEM, AFM, FTIR, DSC and XRD. The in vitro MTT assay, cellular uptake, and apoptosis assay were performed using MDA-MB-231 cell line. The gemini surfactant molecules were able to form vesicles in aqueous solution with a narrow size distribution (PDI congruent to 0.3). An encapsulation efficiency of 87.45 +/- 2.3% and the drug loading content of 4.98 +/- 0.12% were acquired. Curcumin molecules were dispersed in the hydrophobic shell of the vesicles, and sustained release profile was observed. Due to the increased cellular uptake and sustained release profile, the gemini surfactant-curcumin nanocapsules exhibited higher cytotoxicity and enhanced apoptosis in MDA-MB-231 cells compared to free curcumin. The results indicate that gemini surfactant-curcumin complex shows considerable promise as an anti-breast cancer drug.